Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07101978

Hyperthermia in Patients With Chronic Primary Pain - Effects on Thermoregulation, Somatosensory System and Movement Evoked Pain

Influence of Serial Whole-body Hyperthermia on Circadian Core Body Temperature, the Somatosensory System and Movement Evoked Pain: Differences Between Healthy Subjects and Patients With Chronic Primary Pain

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Bern University of Applied Sciences · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study, in a quasi-experimental pre-post design, investigates the effect of serial water-filtered whole-body hyperthermia on circadian core body temperature, the somatosensory system (nociception) and pain perception in healthy and patients with chronic primary pain (e.g., fibromyalgia). The intervention lasts 3 weeks with two treatment sessions per week.

Detailed description

A total of 30 healthy participants and 30 participants with chronic primary pain between the ages of 18 and 70 are being sought. All participants will receive the same amount of water-filtered whole-body hyperthermia in outpatient or semi-inpatient treatment. All abnormalities and side effects will be documented by the responsible therapists and doctors. Changes in circadian core body temperature, sensory or nociceptive sensitivities of the somatosensory system, and movement-evoked pain will be recorded, and blood parameters for nociceptive plasticity will be collected. For secondary efficacy, specific questionnaires on pain experience, fatigue, depression, and fear avoidance behavior will be collected 7 and 25 weeks after therapy.

Conditions

Interventions

TypeNameDescription
BEHAVIORALserial whole body hyperthermiaThe hyperthermia treatment is carried out in a cycle of two treatments per week, with at least one day in between, over a period of three weeks, according to the manufacturer's instructions. According to the guidelines, the rectal (possibly vaginal) temperature (as body core temperature), heart rate and oxygen saturation (Sp02) are continuously determined during the hyperthermiatreatment. During the treatment, continuous supervision by trained personnel is guaranteed, and a doctor is on call.

Timeline

Start date
2026-01-01
Primary completion
2027-06-30
Completion
2028-01-01
First posted
2025-08-03
Last updated
2025-08-03

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT07101978. Inclusion in this directory is not an endorsement.